Sign in

TCDA on NASDAQ

Tricida

Pharmaceutical company based in Menlo Park, founded in 20131

In its 2022 annual report the company says: “We are a pharmaceutical company focused on the development and commercialization of our investigational drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract.”53 Its shares trade on NASDAQ under the symbol TCDA.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Jan 1, 2013Founded1

Compare with another stock.

  • TickerTCDA on NASDAQ1
  • Industrypharmaceutical industry1
  • HeadquartersMenlo Park1
  • Websitewww.tricida.com
  • Legal formDelaware corporation1
  • Incorporated inDE4
  • Business address7000 Shoreline Court, Suite 201, South San Francisco, Ca 940804
  • Filer categoryNon-accelerated filer, Smaller reporting company4
  • LEI549300QVPFFJC8SZXG253
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 53388643

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income5678-$153.0M in 2021+463% since 2016
-$300.0M-$200.0M-$100.0M02016: -$27.2M-$27.2M20162017: -$47.1M-$47.1M2017+73%2018: -$103.6M-$103.6M2018+120%2019: -$178.8M-$178.8M2019+73%2020: -$251.4M-$251.4M2020+41%2021: -$153.0M-$153.0M2021−39%
Net income5678-$176.6M in 2021+516% since 2016
-$300.0M-$200.0M-$100.0M02016: -$28.7M-$28.7M20162017: -$41.3M-$41.3M2017+44%2018: -$102.8M-$102.8M2018+149%2019: -$176.8M-$176.8M2019+72%2020: -$264.8M-$264.8M2020+50%2021: -$176.6M-$176.6M2021−33%
Fiscal year20152016201720182019202020212022
Research and development$21.8M5$35.9M6$85.6M7$133.0M7$148.4M8$115.4M8
Selling, general and admin$5.4M5$11.2M6$18.0M7$45.8M7$103.0M8$37.6M8
Operating expenses$153.0M8
Operating income-$27.2M5-$47.1M6-$103.6M7-$178.8M7-$251.4M8-$153.0M8
Interest$05$06$3.1M7$5.7M7$18.4M8$17.6M8
Income tax$06$07-$92.0K7$08$08
Net income-$28.7M5-$41.3M6-$102.8M7-$176.8M7-$264.8M8-$176.6M8
Earnings per share-$5.298-$3.448
Earnings per share (diluted)-$5.298-$3.448
Shares (weighted, basic)51.3M shares8
Shares (weighted, diluted)51.3M shares8

Compare Tricida with another company

Corporate structure

Tricida sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Tricida

  • Tricida San Francisco, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Tricida reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$5.3M8 Dec 31, 2021$5.3M8 Dec 31, 2020−0.9%
Accumulated depreciation$4.5M8 Dec 31, 2021$4.2M8 Dec 31, 2020+7.0%
Property and equipment, net$769.0K8 Dec 31, 2021$1.1M8 Dec 31, 2020−30.8%
Operating-lease assets (leased space)$12.2M8 Dec 31, 2021$13.8M8 Dec 31, 2020−11.9%

Real estate and locations

ItemLatestA year beforeChange
Area of real estate46,074 sq ft8 Dec 31, 202146,074 sq ft7 Sep 1, 20200%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$21.1M8 Dec 31, 2021$137.9M8 Dec 31, 2020−84.7%
Marketable securities, current$119.4M8 Dec 31, 2021$171.7M8 Dec 31, 2020−30.4%
Marketable securities, non-current$10.0M8 Dec 31, 2021$22.8M8 Dec 31, 2020−55.9%
Debt securities available for sale$129.5M8 Dec 31, 2021$304.4M7 Dec 31, 2020−57.5%

Leadership

Who has led Tricida, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Gerrit Klaerner2018–2022

President

  1. Gerrit Klaerner2018–2022
201520202025
Board members and other officers (17)

Timeline

  1. Jun 13, 20238-K Bankruptcy or receivership; Change to shareholders' rights; Other events28
  2. May 25, 20238-K Bankruptcy or receivership; Regulation FD disclosure29
  3. Apr 26, 20238-K Regulation FD disclosure30
  4. Mar 24, 20238-K Regulation FD disclosure31
  5. Mar 21, 20238-K Executive or director change32
  6. Mar 15, 20238-K Completed an acquisition or sale33
  7. Feb 24, 20238-K Entered a material agreement34
  8. Feb 23, 20238-K Regulation FD disclosure35
  9. Feb 17, 20238-K Other events36
  10. Jan 27, 20238-K Executive or director change37
  11. Jan 17, 20238-K Listing notice or transfer38
  12. Jan 12, 20238-K Entered a material agreement; Bankruptcy or receivership; Debt or obligation accelerated39
  13. Jun 27, 2018New chief executive Gerrit Klaerner becomes CEO11
  14. Jan 1, 2013Founded Founded1

Calendar

When it reported results

  1. Nov 14, 2022Reported quarterly or annual results40
  2. Aug 8, 2022Reported quarterly or annual results41
  3. May 10, 2022Reported quarterly or annual results42
  4. Mar 29, 2022Reported quarterly or annual results43
  5. Jan 10, 2022Reported quarterly or annual results44
  6. Nov 8, 2021Reported quarterly or annual results45

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

130 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 32 major events, 62 insider forms, 17 large holders, 14 other. The latest 20:

  1. Jun 16, 2023EFFECT EDGAR
  2. Jun 13, 202315-12G EDGAR
  3. Jun 13, 2023S-8 POS EDGAR
  4. Jun 13, 2023POSASR EDGAR
  5. Jun 13, 2023POS AM EDGAR
  6. Jun 13, 20238-K EDGAR
  7. May 25, 20238-K EDGAR
  8. Apr 26, 20238-K EDGAR
  9. Mar 24, 20238-K EDGAR
  10. Mar 21, 20238-K EDGAR
  11. Mar 15, 20238-K EDGAR
  12. Feb 24, 20238-K EDGAR
  13. Feb 23, 20238-K EDGAR
  14. Feb 17, 20238-K EDGAR
  15. Feb 14, 2023SC 13G/A EDGAR
  16. Feb 14, 2023SC 13G/A EDGAR
  17. Feb 14, 2023SC 13G/A EDGAR
  18. Feb 14, 2023SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 EDGAR
  19. Jan 27, 20238-K EDGAR
  20. Jan 17, 20238-K EDGAR

The 130 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

78 open-market trades by officers, directors and large owners since October 2021: 45 buys and 33 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 25, 2022ORBIMED ADVISORS LLCDirectorSale3,629,226$0.22$798.4KForm 4
Nov 25, 2022Bonita David PDirectorSale3,629,226$0.22$798.4KForm 4
Nov 23, 2022Alpern Robert JDirectorSale131,879$0.21$27.7KForm 4
Nov 23, 2022ORBIMED ADVISORS LLCDirectorSale5,617,300$0.21$1.2MForm 4
Nov 23, 2022Bonita David PDirectorSale5,617,300$0.21$1.2MForm 4
Nov 22, 2022ORBIMED ADVISORS LLCDirectorSale1,034,421$0.22$227.6KForm 4
Nov 22, 2022Bonita David PDirectorSale1,034,421$0.22$227.6KForm 4
Nov 21, 2022Alpern Robert JDirectorSale27,584$0.23$6.3KForm 4
Oct 26, 2022Venrock Healthcare Capital Partners II, L.P.10% ownerSale2,367,174$0.46$1.1MForm 4
Oct 25, 2022Venrock Healthcare Capital Partners II, L.P.10% ownerSale1,970,418$0.57$1.1MForm 4
Oct 24, 2022Venrock Healthcare Capital Partners II, L.P.10% ownerSale2,113,948$0.61$1.3MForm 4
Oct 19, 2022Venrock Healthcare Capital Partners II, L.P.10% ownerBuy311,466$10.51$3.3MForm 4
Oct 18, 2022Venrock Healthcare Capital Partners II, L.P.10% ownerBuy40,400$11.98$484.0KForm 4
Oct 17, 2022Shah Nimish P10% ownerBuy170,292$11.67$2.0MForm 4
Oct 13, 2022Sibling Capital Fund II-C L.P.Sale29,332$11.99$351.7KForm 4
Oct 13, 2022Shah Nimish P10% ownerBuy4,674$11.98$56.0KForm 4
Oct 12, 2022Sibling Capital Fund II-C L.P.Sale212,283$12.53$2.7MForm 4
Oct 11, 2022Sibling Capital Fund II-C L.P.Sale118,385$12.01$1.4MForm 4
Oct 11, 2022Shah Nimish P10% ownerBuy25,000$11.85$296.2KForm 4
Oct 10, 2022Shah Nimish P10% ownerBuy80,314$11.89$954.9KForm 4

All 78 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Tricida is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARTricida, Inc.2
  • CIK0001595585
  • Employer ID (EIN)46-33725262
  • Filer statusNon-accelerated filer<br>smaller reporting company2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address7000 Shoreline Court, Suite 201, South San Francisco, CA 940802
  • Phone415-429-78002
  • Shares outstanding58,028,254 as of Nov 9, 202210
  • Public float$100.0M as of Jun 30, 20218
  • On EDGAR sinceJan 30, 20142
  • Filings519 in all: 4 (285), 8-K (82), 3 (25), 10-Q (14), SC 13G/A (14), SC 13D/A (9), SC 13G (9), CORRESP (7)2
    All 43 form types

    S-8 (6), DEFA14A (5), EFFECT (5), UPLOAD (5), 10-K (4), D (4), DEF 14A (4), S-1/A (3), SC 13D (3), 4/A (2), 424B4 (2), DRS (2), DRS/A (2), DRSLTR (2), PRE 14A (2), S-1 (2), S-1MEF (2), S-3 (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 424B5 (1), 5 (1), 8-A12B (1), 8-K/A (1), CERT (1), CT ORDER (1), FWP (1), POS AM (1), POSASR (1), S-3/A (1), S-3ASR (1), S-8 POS (1), SC TO-I (1), SC TO-I/A (1)

  • Latest filingsAnnual report (10-K) Mar 29, 2022
    Quarterly report (10-Q) Nov 14, 2022
    Proxy statement (DEF 14A) Apr 25, 2022
    Latest 8-K (8-K) Jun 13, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
    SEC EDGAROther events
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53